GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...
Innovative Patient-Friendly Device Combines Safety of Extravascular Sealant and Security of Mechanical Closure to Provide Consistent Results “We are proud of the advantages Mynx Ace offers to femoral ...
On the basis of outcomes, there was no clear winner from a trial that directly compared two modern devices used in patients undergoing percutaneous left atrial appendage (LAA) closure. But the devices ...
Please provide your email address to receive an email when new articles are posted on . Published results showed lumbar microdiscectomy with a bone-anchored annular closure device for treatment of ...
Initial data looking at safety and efficacy of an interatrial septal occluder with a bioresorbable frame show promise for closing atrial septal defects (ASDs), but the study authors suggest a redesign ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a second-generation left atrial appendage closure device for patients with nonvalvular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results